Is the use of the `transfer to utility' method valid in economic analyses?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1457, 2004-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Which discounting method best for pharmacoeconomic analyses?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Which discounting method best for pharmacoeconomic analyses?

Inpharma, Vol. 1, Iss. 1497, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

How Often Do Sensitivity Analyses for Economic Parameters Change Cost-Utility Analysis Conclusions?

By Schackman B.R.

PharmacoEconomics, Vol. 22, Iss. 5, 2004-01 ,pp. : 293-300

Adis International

Access to resources Recommend Favorite

Is the evidence recommending pneumococcal vaccine valid?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 376, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Bivalirudin monotherapy a valid option in ACS?

Inpharma, Vol. 1, Iss. 1584, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite